Equity

HDFC

Focused Fund

Equity

An open ended equity scheme investing in maximum 30 stocks in large-cap, mid-cap and small-cap category (i.e. Multi-Cap).

The Scheme would have the flexibility to invest across market capitalization in stocks with high growth potential. It follows a focused approach to investing in a portfolio of up to 30 high conviction stocks which are expected to outperform the market over the medium to long term*.

*As per the current investment strategy. There is no assurance that the investment objective of the Scheme will be realized. For complete investment strategy and other details, refer SID

Exit Load

● In respect of each purchase/switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed/switched-out within 1 year from the date of allotment.
● No Exit Load is payable if Units are redeemed/switched-out after 1 year from the date of allotment.
No Entry/Exit Load shall be levied on bonus units and units allotted on dividend reinvestment

Performance

No data available
Scheme Returns (%)
Benchmark Returns (%)#
Additional Benchmark Returns (%)##
Value of Investment of Rs 10,000
Scheme Returns (Rs.)
Benchmark (Rs.)#
Additional Benchmark (Rs.)##
  • ^Past performance may or may not be sustained in future and is not a guarantee of any future returns. # Nifty 500 TRI ## BSE Sense...Read More

Fund Managers

Ms. Roshi Jain

Senior Fund Manager - Equities

OVERSEAS

Mr. Dhruv Muchhal

Equity Analyst and Fund Manager for Overseas Investments

Top 10 Holdings

As on 30 Jun 2025

Downloads

HDFC Focused Fund

image

SID - HDFC Focused 30 Fund dated May 30, 2025

image

KIM - HDFC Focused 30 Fund dated May 30, 2025

image

HDFC Focused 30 Fund - Presentation(April 2025)

image

Fund Facts - HDFC Focused 30 Fund_June 25

image

Leaflet

Product Labelling

Risk Icon

Benchmark Riskometer

very high

This product is suitable for investors who are seeking~
• to generate long-term capital appreciation/income
• investments in equity & equity related instruments of up to 30 companies
~Investors should consult their financial advisers if in doubt about whether the product is suitable for them.